NextPlat (NASDAQ:NXPL) Releases Earnings Results

NextPlat (NASDAQ:NXPL) posted its quarterly earnings data on Tuesday. The company reported ($0.24) earnings per share (EPS) for the quarter, FiscalAI reports. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%. The business had revenue of $12.80 million for the quarter.

Here are the key takeaways from NextPlat’s conference call:

• The company completed a reverse split to maintain its Nasdaq listing; management says it was necessary but acknowledges investor negativity despite stating NextPlat has ~$14 million in cash, no debt, and high insider ownership.
• Healthcare showed an early turnaround — 340B contract revenue rose 94% sequentially in Q4, medication fulfillment now exceeds 7,000 prescriptions/month, and a new HealthWarehouse partnership enables expansion from Florida to all 50 states.
• Management implemented >$2 million in annualized cost reductions and cut operating expenses ~25% (salaries down ~20%, professional fees down ~49%), ending the year with strong liquidity and expecting substantially reduced cash burn in 2026.
• Full-year revenue declined ~18% to ~$54 million (healthcare down to ~$40 million from $52M) and consolidated gross margin fell to ~20% from 26% in 2024, though management reports sequential margin improvement and expects gradual recovery in 2026.
• E-commerce remained a growth engine — revenue rose ~6% to ~$15 million, with record device sales, higher recurring airtime revenue, new distribution agreements, defense/NATO contracts, and launches on Mercado Libre in five South American countries.

NextPlat Trading Up 12.0%

NASDAQ:NXPL traded up $0.05 on Monday, hitting $0.50. 247,817 shares of the stock were exchanged, compared to its average volume of 1,297,146. The stock has a market cap of $13.60 million, a PE ratio of -1.14 and a beta of 1.38. NextPlat has a fifty-two week low of $0.34 and a fifty-two week high of $1.11. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The stock has a fifty day moving average of $0.53 and a 200-day moving average of $0.65.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a report on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, NextPlat currently has an average rating of “Sell”.

Institutional Investors Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.